SAMHSA Mandatory Guidelines: The Gold Standard for Workplace Drug Testing Compliance

Why Employers Use Federal Drug Testing Standards as Their Compliance Baseline

According to the U.S. Department of Health and Human Services, more than 2 million federal workplace drug tests are conducted each year under the SAMHSA Mandatory Guidelines.

Source: U.S. Department of Health and Human Services – Mandatory Guidelines for Federal Workplace Drug Testing Programs

These guidelines establish the most legally defensible drug testing framework in the United States. While they are required for federal agencies and DOT-regulated safety-sensitive employees, they are widely adopted by private employers as the best-practice standard for workplace drug testing programs.

For organizations implementing rapid onsite drug screening, aligning with SAMHSA standards demonstrates:

• Policy credibility
• Consistent testing methodology
• Protection in unemployment and termination disputes
• Audit-ready compliance structure

What Are the SAMHSA Mandatory Guidelines?

The Substance Abuse and Mental Health Services Administration (SAMHSA), under the U.S. Department of Health and Human Services (HHS), publishes the Mandatory Guidelines for Federal Workplace Drug Testing Programs.

These guidelines define:

• Specimen collection procedures
• Chain of custody requirements
• Certified laboratory standards
• Medical Review Officer (MRO) verification
• Drug testing cut-off levels
• Quality assurance and result reporting

Source: U.S. Department of Health and Human Services
https://www.samhsa.gov/workplace

Who Is Required to Follow SAMHSA Drug Testing Guidelines?

SAMHSA guidelines are mandatory for:

• Federal executive branch employees in testing-designated positions
• U.S. Department of Transportation (DOT) safety-sensitive employees

DOT-regulated agencies include:

• FMCSA (trucking)
• FAA (aviation)
• FTA (transit)
• FRA (rail)
• PHMSA (pipeline)
• USCG (maritime)

Source: U.S. Department of Transportation – 49 CFR Part 40
https://www.transportation.gov/odapc

Why Private Employers Use SAMHSA as Their Best Practice Model

Although not legally required for most private companies, SAMHSA alignment provides:

• A nationally recognized testing standard
• Defensible results in legal and HR proceedings
• Consistent drug panel selection
• Reduced program risk

This is especially important for employers in:

• Manufacturing
• Healthcare
• Logistics and warehousing
• Construction
• Energy
• Public sector and education

The Federal 5-Panel Drug Test: The Compliance Baseline

The SAMHSA 5-panel drug test is the foundation of all federally regulated workplace drug testing programs.

The 5-panel screens for:

  1. Marijuana (THC metabolites)

  2. Cocaine metabolites

  3. Amphetamines
    • Amphetamine
    • Methamphetamine
    • MDMA (Ecstasy)
    • MDA

  4. Opioids
    • Codeine
    • Morphine
    • Heroin metabolite (6-MAM)
    • Hydrocodone
    • Hydromorphone
    • Oxycodone
    • Oxymorphone

  5. Phencyclidine (PCP)

Source: Federal Register – Mandatory Guidelines for Federal Workplace Drug Testing Programs

Why the 5-Panel Matters for Rapid Onsite Drug Testing Programs

For employers using CLIA-waived rapid drug tests onsite, the 5-panel:

• Provides a federally recognized starting point
• Supports standardized hiring policies
• Aligns with safety-sensitive best practices
• Creates a scalable testing framework

It also allows employers to:

• Expand to 7-, 9-, 10-, or 12-panel programs based on workforce risk
• Maintain consistency across multiple locations
• Implement random testing with a defensible baseline

Key Takeaway for Employers

If your organization is building or upgrading a workplace drug testing program, the SAMHSA 5-panel is not just a federal requirement — it is the national compliance benchmark.

Using this model for your onsite rapid testing program helps ensure your policy is:

• Credible
• Consistent
• Legally defensible
• Aligned with federal best practices

How My BIO TESTS® Supports SAMHSA-Aligned Rapid Drug Testing Programs

My BIO TESTS® helps employers implement:

• CLIA-waived rapid drug testing solutions
• Risk-based panel selection
• Onsite testing workflows
• Scalable multi-location programs

All built on federally recognized compliance frameworks.

Sources

U.S. Department of Health and Human Services (HHS)
Mandatory Guidelines for Federal Workplace Drug Testing Programs
https://www.samhsa.gov/workplace

U.S. Department of Transportation
49 CFR Part 40 – Drug and Alcohol Testing Procedures
https://www.transportation.gov/odapc

Federal Register
Mandatory Guidelines for Federal Workplace Drug Testing Programs

Back to blog